Heartland Advisors Inc. Purchases Shares of 29,632 Humana Inc. $HUM

Key Points

• Heartland Advisors acquired 29,632 Humana shares in the second quarter, worth approximately $11.77 million. Institutional investors and hedge funds collectively own 92.38% of HUM.
• Analyst sentiment is mixed but improving: Humana has a consensus “Hold” rating and an average price target of $395.22, with recent upgrades from Evercore and Bank of America.
• Humana reported quarterly earnings of $7.61 per share, exceeding estimates, while revenue rose 26.2% year over year to $40.89 billion. The stock opened at $379.22, near its $395.22 consensus target.

Heartland Advisors Inc. acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 29,632 shares of the insurance provider's stock, valued at approximately $11,770,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Montag A & Associates Inc. boosted its holdings in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider's stock worth $25,000 after buying an additional 94 shares during the period. Johnson Financial Group Inc. acquired a new stake in Humana during the second quarter worth approximately $26,000. Fideuram Asset Management Ireland dac acquired a new stake in Humana during the fourth quarter worth approximately $27,000. Trust Co. of Vermont bought a new stake in shares of Humana during the second quarter worth approximately $28,000. Finally, Reflection Asset Management bought a new stake in shares of Humana during the fourth quarter worth approximately $29,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Jefferies Financial Group upgraded Humana from a "buy" rating to a "buy" rating in a research note on Wednesday, May 20th. Truist Financial boosted their price target on Humana from $320.00 to $415.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th. Evercore raised Humana from an "in-line" rating to an "outperform" rating and set a $480.00 price objective on the stock in a report on Wednesday, July 29th. Bank of America upgraded Humana from a "neutral" rating to a "buy" rating and set a $500.00 price objective on the stock in a research report on Wednesday, July 29th. Finally, Zacks Research downgraded Humana from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 11th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Humana has a consensus rating of "Hold" and a consensus price target of $395.22.

Humana Stock Performance

HUM opened at $379.22 on Friday. The firm has a market cap of $45.54 billion, a P/E ratio of 35.88, a price-to-earnings-growth ratio of 2.18 and a beta of 0.72. The business's fifty day moving average is $383.38 and its 200-day moving average is $281.59. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to analysts' expectations of $40.58 billion. During the same quarter in the prior year, the business posted $6.27 earnings per share. Humana's revenue was up 26.2% compared to the same quarter last year. Sell-side analysts expect that Humana Inc. will post 9.08 EPS for the current fiscal year.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source